Chemoinformaics analysis of beta-Copaene-4alpha-ol
Molecular Weight | 220.356 | nRot | 1 |
Heavy Atom Molecular Weight | 196.164 | nRig | 13 |
Exact Molecular Weight | 220.183 | nRing | 4 |
Solubility: LogS | -4.286 | nHRing | 0 |
Solubility: LogP | 3.543 | No. of Aliphatic Rings | 4 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 4 | No. Saturated Carbocycles | 4 |
No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 4 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 41.855 |
nHD | 1 | BPOL | 24.077 |
QED | 0.673 |
Synth | 5.593 |
Natural Product Likeliness | 3.312 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.094 |
HIA | 0.003 |
CACO-2 | -4.51 |
MDCK | 0.0000393 |
BBB | 0.573 |
PPB | 0.7091 |
VDSS | 0.845 |
FU | 0.2261 |
CYP1A2-inh | 0.382 |
CYP1A2-sub | 0.456 |
CYP2c19-inh | 0.028 |
CYP2c19-sub | 0.894 |
CYP2c9-inh | 0.033 |
CYP2c9-sub | 0.221 |
CYP2d6-inh | 0.006 |
CYP2d6-sub | 0.48 |
CYP3a4-inh | 0.085 |
CYP3a4-sub | 0.321 |
CL | 10.896 |
T12 | 0.413 |
hERG | 0.03 |
Ames | 0.013 |
ROA | 0.692 |
SkinSen | 0.048 |
Carcinogencity | 0.025 |
EI | 0.197 |
Respiratory | 0.952 |
NR-Aromatase | 0.007 |
Antiviral | Yes |
Prediction | 0.909264 |